Ariad Pharmaceuticals: PharmaVitae Report - new company profile report published

companiesandmarkets.com

2012-06-12 19:09:26 - Ariad Pharmaceuticals: PharmaVitae Report - a new company profile report on companiesandmarkets.com

This analysis evaluates the company´s strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company´s historical and forecast financial performance. The report also gives an in-depth analysis of the company´s key prescription pharmaceutical product, and provides a forecast sales performance for this drug.

Report Scope

- Gain insight into Ariad Pharmaceuticals´ strategic outlook
- Analyze company sales forecasts

 

 

by product

Key Highlights

Ariad´s most advanced product candidate is ponatinib, which the company believes has potential in hematological cancers and solid tumors. It is in a pivotal Phase II trial and Ariad plans to file for marketing approval of ponatinib in the US and Europe in the third quarter of 2012.

Ariad´s second-closest product to approval is AP26112, an investigational dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR). These are both targets in non-small cell lung cancer (NSCLC). Depending on the outcome of a Phase I/II trial, Ariad envisions starting a pivotal trial in NSCLC patients in 2013.

Reasons to Buy

- Benchmark Ariad Pharmaceuticals´ performance against key rivals in the prescription pharmaceutical sector
- Assess how successful Ariad Pharmaceuticals will be in obtaining marketing approval for its first product

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Company Profile Reports www.companiesandmarkets.com/Market/All/Company-Profile?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.